Everlywell Current Valuation and Market Capitalization
Everlywell is a direct-to-consumer health testing company that provides at-home collection kits for hormones, vitamins, food sensitivities, and sexually transmitted infections. As of the most recent public data, Everlywell is a privately held company, so its exact market capitalization is not listed on a public stock exchange. The latest available valuation and funding figures are drawn from private market databases and disclosed funding rounds. For the most up-to-date private company data, see the Everlywell profile on Crunchbase Crunchbase Everlywell page.
The company has raised multiple rounds of venture capital since its founding, with the most recent major funding round pushing its post-money valuation into the billions. Investors include traditional healthcare and technology-focused venture firms, and the company has used the capital to expand its test menu and digital health platform. Because Everlywell is not publicly traded, its worth is inferred from disclosed funding valuations, secondary market reports, and comparable company analysis rather than a live stock price.
Revenue, Business Model, and Financial Performance
Everlywell operates a direct-to-consumer model in which customers purchase test kits online, collect samples at home, and receive digital results through a secure portal. Revenue is generated primarily from kit sales, subscription panels, and partnerships with health plans and employers. The company has grown its customer base by emphasizing convenience, CLIA-certified laboratories, and physician-reviewed results, positioning itself alongside telehealth and at-home diagnostic competitors.
Revenue Growth and Business Segments
Publicly reported revenue figures for Everlywell are limited because the company remains private, but industry analyses and investor materials indicate strong year-over-year growth driven by expanding test categories and recurring subscription revenue. Key business segments include wellness and lifestyle testing, sexual health, women's health, and chronic condition monitoring, with additional revenue from corporate wellness programs and health system partnerships. For context on how direct-to-consumer health companies scale, see the overview of telehealth and at-home testing trends on the FDA website FDA telehealth and remote monitoring page.
Funding History, Investors, and Comparable Companies
Everlywell has completed several venture funding rounds since its inception, with cumulative capital raised exceeding one billion dollars. The company's investors include major venture capital firms and strategic healthcare investors, and its valuation has increased with each round as revenue and test volume grew. Comparable companies in the at-home diagnostics and telehealth space include LetsGetChecked, myLAB Box, and Hims Hers, which have also attracted significant private and public market capital.
Private vs Public Company Valuation Context
Because Everlywell is private, its worth is determined by the price paid in its most recent funding round and the implied valuation from investors. Publicly traded competitors and peers provide a benchmark for revenue multiples and growth rates, and analysts use these comparisons to estimate Everlywell's current and potential future value. For information on how private company valuations are assessed, see the U.S. Securities and Exchange Commission's guidance on private company reporting SEC EDGAR company filings.